Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Dual targeting of endothelial cells and pericytes in antivascular therapy for ovarian carcinoma.

Lu C, Kamat AA, Lin YG, Merritt WM, Landen CN, Kim TJ, Spannuth W, Arumugam T, Han LY, Jennings NB, Logsdon C, Jaffe RB, Coleman RL, Sood AK.

Clin Cancer Res. 2007 Jul 15;13(14):4209-17.

2.

The enigmatic role of angiopoietin-1 in tumor angiogenesis.

Metheny-Barlow LJ, Li LY.

Cell Res. 2003 Oct;13(5):309-17. Review.

3.

Antibody-directed targeting of the vasculature of solid tumors.

Thorpe PE, Burrows FJ.

Breast Cancer Res Treat. 1995;36(2):237-51. Review.

PMID:
8534871
4.

Diversity within pericytes.

Sims DE.

Clin Exp Pharmacol Physiol. 2000 Oct;27(10):842-6. Review.

PMID:
11022980
5.

Pharmacological aspects of targeting cancer gene therapy to endothelial cells.

Sedlacek HH.

Crit Rev Oncol Hematol. 2001 Mar;37(3):169-215. Review.

PMID:
11248576
6.

Mechanisms of pericyte recruitment in tumour angiogenesis: a new role for metalloproteinases.

Chantrain CF, Henriet P, Jodele S, Emonard H, Feron O, Courtoy PJ, DeClerck YA, Marbaix E.

Eur J Cancer. 2006 Feb;42(3):310-8. Review.

PMID:
16406506
7.

Pericytes and vascular stability.

von Tell D, Armulik A, Betsholtz C.

Exp Cell Res. 2006 Mar 10;312(5):623-9. Review.

PMID:
16303125
8.
9.

Targeting tumor blood vessels: an adjuvant strategy for radiation therapy.

Siemann DW, Warrington KH, Horsman MR.

Radiother Oncol. 2000 Oct;57(1):5-12. Review.

PMID:
11033183
10.

Pericytes: a double-edged sword in cancer therapy.

Meng MB, Zaorsky NG, Deng L, Wang HH, Chao J, Zhao LJ, Yuan ZY, Ping W.

Future Oncol. 2015;11(1):169-79. doi: 10.2217/fon.14.123. Review.

PMID:
25143028
11.

The great escape; the hallmarks of resistance to antiangiogenic therapy.

van Beijnum JR, Nowak-Sliwinska P, Huijbers EJ, Thijssen VL, Griffioen AW.

Pharmacol Rev. 2015;67(2):441-61. doi: 10.1124/pr.114.010215. Review.

12.

Cellular abnormalities of blood vessels as targets in cancer.

Baluk P, Hashizume H, McDonald DM.

Curr Opin Genet Dev. 2005 Feb;15(1):102-11. Review.

PMID:
15661540
13.

Intratumor microvessel density as a prognostic factor in cancer.

Weidner N.

Am J Pathol. 1995 Jul;147(1):9-19. Review. No abstract available.

14.

Pericyte biology and diseases.

Yamagishi S, Imaizumi T.

Int J Tissue React. 2005;27(3):125-35. Review.

PMID:
16372479
15.

Pericytes: cell biology and pathology.

Allt G, Lawrenson JG.

Cells Tissues Organs. 2001;169(1):1-11. Review.

PMID:
11340256
16.

Endothelial cells as therapeutic targets in cancer: new biology and novel delivery systems.

Murray JC, Moghimi SM.

Crit Rev Ther Drug Carrier Syst. 2003;20(2-3):139-52. Review.

PMID:
14584522
17.

Pericytes and their role in microvasculature homeostasis.

Edelman DA, Jiang Y, Tyburski J, Wilson RF, Steffes C.

J Surg Res. 2006 Oct;135(2):305-11. Review.

PMID:
16930620
18.

Vascular problems of the pelvis.

Bergamini TM, Edwards MJ.

J Surg Oncol. 2000 Apr;73(4):263-72. Review.

PMID:
10797343
19.

Pericyte-targeting drug delivery and tissue engineering.

Kang E, Shin JW.

Int J Nanomedicine. 2016 May 27;11:2397-406. doi: 10.2147/IJN.S105274. Review.

20.

Recent advances in pericyte biology--implications for health and disease.

Sims DE.

Can J Cardiol. 1991 Dec;7(10):431-43. Review.

PMID:
1768982

Supplemental Content

Support Center